What is bio:cap?
bio:cap is the new international INVESTIVAL for innovators and investors in life sciences and AI - where bold ideas meet capital, industry, and policy to become reality.
From 9 - 11 June 2026 at CityCube Berlin, the city becomes a global meeting point - bridging North America and Asia. Across BioTech, TechBio, Diagnostics, and AI, bio:cap is where scientific breakthroughs, industrial innovation, and public decision-making converge.
What to expect?
Hosted by Messe Berlin under the patronage of Charité – Universitätsmedizin Berlin and the Berlin Institute of Health (BIH), and supported by the Hasso Plattner Institute (HPI), bio:cap blends conference and festival into a dynamic, interdisciplinary platform for discovery, investment, and action.
Our mission: connect visionary investors and cutting-edge bio- and tech innovators with global pharma leaders and key policymakers - to fuel breakthroughs, back high-potential ventures, and shape the frameworks that turn Europe’s science into global market success.
_xxxldesk43.jpg&w=3840&q=75)
Matchmaking & Partnering
Curated 1:1 meetings connect start-ups & scale-ups with international investors. A dedicated pitch stage gives founders the spotlight to showcase their innovations and secure funding.
Inspiration through Keynotes
Industry visionaries, global pharma leaders, policymakers, and top minds at the AI–life sciences frontier share agenda-setting insights and shape what’s next.
Networking, Berlin-style
Business during the day, club night after dark - all in Berlin’s unmistakable atmosphere.
Political Exchange
Special panels bring innovators and government representatives together to discuss regulatory frameworks and future strategies.
Who’s coming?
- Pharma and industry leaders seeking innovation and strategic partnerships.
- Start-ups & Scale-ups in BioTech, TechBio, Diagnostics, and AI seeking capital and growth.
- VCs, corporate VCs, family offices, private equity firms, high-net-worth individuals, and business angels on the hunt for the next breakthrough.
- International decision-makers from governments, funding agencies, and industry associations shaping the future framework of Europe’s life science ecosystem.
Why Berlin?
Berlin is Germany’s undisputed start-up capital—a magnet for talent, capital, and creativity. Together with Brandenburg, it forms one of Europe’s largest science clusters, blending world-class research, entrepreneurial energy, and a thriving creative scene. The result? The perfect setting for an Investival.
At the crossroads of biotech, AI, and digital health, Berlin is shaping the future—from molecular diagnostics and personalized therapies to digital drug twins. bio:cap brings these synergies to life: a platform for data-driven biomedicine, a stage for groundbreaking partnerships, and a catalyst for high-impact investment in the next era of life sciences.
As the political heart of Europe, Berlin is where strategies for science and growth are forged—and where policies that matter to investors and founders take shape. Add a rich history, cutting-edge tech hubs, and legendary nightlife, and you have the ultimate home for bio:cap.